申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2001098248A2
公开(公告)日:2001-12-27
The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the formula (I), or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or prodrug of said compound or of a tautomer thereof, wherein R1 is phenyl, wherein said phenyl is substituted from 1-3 times with R?2, or R1¿ naphthyl, and wherein said naphthyl is optionally substituted from 1-3 times with R2; each R2 is independently selected from halo, C¿1?-C3 alkyl, C1-C2 alkoxy, C1-C3 haloalkyl, and phenyl-(CH2)mOn-; m is 0 or 1; n is 0 or 1; and Z is methylene or -C(O)-, provided that when Z is -C(O)- said substituted phenyl is not ortho-chloro phenyl.